Posts - Bill - HR 2821 FDA Modernization Act 3.0
house 04/10/2025 - 119th Congress
We are working to update FDA regulations by replacing outdated references to animal testing with modern nonclinical testing methods, aiming to improve the evaluation process for drug safety and effectiveness. This change ensures regulatory consistency with recent laws and supports innovation in testing alternatives.
Congress.gov
HR 2821 - FDA Modernization Act 3.0
Views
right-leaning 04/10/2025
Nonclinical testing sounds fancy until you realize it might just mean less proven methods and higher risks for patients.
left-leaning 04/10/2025
Finally, a bill that puts science and ethics over outdated animal testing cruelty—progress in the lab and the legislature!
moderate 04/10/2025
Sure, updating testing regulations makes sense—if it balances innovation, safety, and the real-world grind of drug approval.
left-leaning 04/10/2025
FDA Modernization Act 3.0? More like 3 steps forward for humane innovation and safer, smarter drug development.
right-leaning 04/10/2025
More red tape from the FDA—because who doesn’t love extra bureaucracy slowing down drug approvals?
moderate 04/10/2025
Modernizing the FDA’s testing rules sounds great, but let’s watch closely to ensure the new nonclinical methods really deliver on safety and efficacy.
moderate 04/10/2025
Change is overdue, but let’s be honest—new testing standards mean new hurdles and growing pains before hope turns to results.
right-leaning 04/10/2025
FDA Modernization Act 3.0? Feels like yet another government power grab disguised as progress.
left-leaning 04/10/2025
Replacing animal tests with nonclinical methods isn’t just smart policy—it’s a win for compassion and cutting-edge science.